The newly approved oral medication Pivya provides women with another option for treating uncomplicated urinary tract ...
The Food and Drug Administration recently approved Pivya (pivmecillinam) to treat uncomplicated UTIs in female adults.
Pivmecillinam, which has been used in Europe for decades, will become available next year to women 18 and older.
The US Food and Drug Administration has approved pivmecillinam (Pivya) tablets to treat uncomplicated urinary tract ...
The approval was based on data from 3 phase 3 trials which compared the efficacy of different dosing regimens of ...
The Food and Drug Administration (FDA) has approved Pivya (pivmecillinam) for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infections (UTIs) caused by ...
The U.S. Food and Drug Administration has approved oral pivmecillinam for the treatment of female adults with uncomplicated ...
The U.S. Food and Drug Administration has approved Pivya (pivmecillinam) tablets for the treatment of female adults with ...
"The FDA is committed to fostering new antibiotic availability when they prove to be safe and effective, and Pivya will ...
Uncomplicated urinary tract infections is a very common condition impacting women and the most frequent reason for antibiotic ...